Standard vs Adaptive Recovery Management Checkups (033)
Study Information
The Chestnut Health Systems JCOIN Research Center is comparing the effectiveness of the Recovery Management Checkups (RMC) model, an evidence-based intervention that provides regular, fixed schedule check-ups to support treatment retention and recovery, and an adaptive model (RMC-Adapted) that tailors check-up frequency and intensity to individualsโ needs. Each condition offers justice-involved individuals referral or assertive linkage to a designated treatment provider upon release from jail.
The study will be conducted in six county jails across Illinois, with the goal of increasing linkage to, and retention in, evidence-based treatment in the community, while reducing relapse and recidivism.
Study Settings: Jails/Prisons, Treatment/Healthcare Settings
Study Location: Illinois
Publications:
- Improving retention across the OUD service cascade upon reentry from jail using Recovery Management Checkups-Adaptive (RMC-A) experiment (2021)
- Navigating intersecting public health crises: A qualitative study of people with OUDโs experiences during the COVID-19 pandemic (2022)
- Workforce outcomes among substance use peer supports and their contextual determinants: A scoping review protocolย (2024)
- “They Don’t Give You No Note If It’s Got Fentanyl”: Using Cognitive Interviews to Understand Self-report and Urine Drug Screen Discrepancies (2025)
- Advancing peer support workforce research: Insights and recommendations through the lens of professionalization (2024)
Grant number: UG1DA050065
Link to NIH Reporter record: https://reporter.nih.gov/project-details/9882856
Study Team
PI: Michael Dennis, Christine Grella
โข Compare the effectiveness of the RMC model to the RMC-Adapted model
โข Facilitate linkage to medications for opioid use disorder (MOUD) and other treatment services upon release from jail
โข Measure outcomes including MOUD initiation, retention, relapse and recidivism
โข Estimate the costs and cost effectiveness of implementing adaptive RMCs
Clinical Trial, Linkage Strategies